Nordion reports higher medical isotope revenues

Guest Contributor
January 31, 2011

Nordion Inc reported a significant increase in revenue derived from the sale of medical isotopes with the return of the NRU reactor to service. Sales of medical isotopes for Q4/10 were $94.4 million, up 49% from Q4/09 sales of $58.0 million. Revenues for the whole year were down slightly, however, from $240.4 million in 2009 to $231.3 million in 2010. A reduction in medical isotopes resulting from a scheduled one-month shut-down of the NRU in April will be partially offset by the start of medical isotopes from Nordion's Russian supplier, Isotope....


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.